Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Viking Therapeutics, Inc. has filed 639 SEC EDGAR filings since 22 May 2014

SEC filing history

Showing 451-475 of 639 matching filings.

Per page
25
Current page
19
4

FORM 4 SUBMISSION

Filing date
03 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jan 2018
Reporting date
02 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
29 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-222202

S-1

Filing date
20 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88828

SCHEDULE 13G

Filing date
19 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88828

SC 13G

Filing date
18 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37355

8-K

Filing date
11 Dec 2017
Reporting date
11 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-212134

424B5

Filing date
07 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37355

8-K - PRICING OF PUBLIC OFFERING

Filing date
07 Dec 2017
Reporting date
06 Dec 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-212134

DECEMBER 424B5

Filing date
05 Dec 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37355

8-K VK5211 PHASE 2 RESULTS

Filing date
28 Nov 2017
Reporting date
28 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37355

8-K Q3 FINANCIAL RESULTS

Filing date
08 Nov 2017
Reporting date
08 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-220992

EFFECT filing

Filing date
26 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-220992

424B3

Filing date
26 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
24 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
24 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-220992

FORM S-1

Filing date
17 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-212134

424B5

Filing date
29 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37355

8-K

Filing date
29 Sep 2017
Reporting date
28 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37355

8-K

Filing date
09 Aug 2017
Reporting date
09 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37355

8-K

Filing date
06 Jul 2017
Reporting date
01 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .